State budget has ‘positive steps’ but does not do enough for providers, residents, groups say
By
Lois A. Bowers
Jul 22, 2024
Senior living industry advocates in Pennsylvania say they are encouraged by steps to support older adults evident in the recently passed state budget, but they say much more needs to be done to support...
Alzheimer’s Association calls for federal involvement to increase dementia care workforce, training...
By
Lois A. Bowers
Jan 29, 2024
“Congress should consider the steps it can take at the federal level, including expanding the necessary workforce and improving dementia training standards and access,” as part of efforts to “help...
Memory care certification launches for assisted living communities
By
Lois A. Bowers
Jul 12, 2023
The Joint Commission, in collaboration with the Alzheimer’s Association, has launched a memory care certification program for assisted living communities.
43 recommendations help fill gap in medical and mental healthcare guidance for assisted living, experts...
By
Lois A. Bowers
Oct 03, 2022
Forty-three recommendations from a new study will guide medical and mental healthcare in assisted living, the authors say.
Should residents’ access to Alzheimer’s drug be restricted?
By
Lois A. Bowers
Jan 18, 2022
You have until Feb. 10 to share your comments with CMS about its recent proposal related to Alzheimer’s drug aducanumab (Aduhelm).
McKnight’s 40 for 40: Loren Shook
By
Lois A. Bowers
May 04, 2020
Say “memory care” and the first company to come to mind for many industry professionals is Silverado. And when they think of Silverado, they think of Loren Shook, the man who co-founded the Irvine,...
‘Better business model’ needed for dementia care, Senate committee hears
By
Lois A. Bowers
Nov 21, 2019
A “better business model for the diagnosis and care of persons with Alzheimer’s disease” needs to be created, Jason Karlawish, M.D., said Wednesday at a Senate Finance Committee Subcommittee on Health...
Memory care approach cuts antipsychotic med use in more than 50% of residents: study
By
Lois A. Bowers
Nov 18, 2019
A person-centered approach to memory care led to the reduced or discontinued use of off-label antipsychotic medications in more than half of the residents of 53 long-term care communities, including assisted...
Allergan subsidiary settles Alzheimer’s drug lawsuit for $750 million
By
Lois A. Bowers
Oct 31, 2019
Subsidiaries of pharmaceutical company Allergan will pay $750 million to resolve a class action lawsuit from a group of direct purchasers of Alzheimer’s drug Namenda (memantine).
Blood tests and phone apps: The future of diagnosing Alzheimer’s?
By
Lois A. Bowers
Apr 08, 2019
Last week in a blog post, Bill Gates shared some exciting ways that Alzheimer’s disease might be diagnosed in the future.